Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis
OwnerKathrin Schwagerinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerKathrin Schwagerinventor
Estimating the term…
Specific binding members that bind the ED-A isoform of fibronectin for use in methods of diagnosis, detection, imaging and/or treatment of inflammatory bowel disease such as ulcerative colitis and/or for use in delivery to the neovasculature of intestinal tissue of a molecule conjugated to the specific binding member. Specific binding members that bind tenascin-C, especially the A1, A2, A3, A4 and/or D domain tenascin-C large isoform, for use in methods of diagnosis, detection, imaging and/or treatment of ulcerative colitis and/or for use in delivery to the neovasculature of inflammatory bowel disease tissue of a molecule conjugated to the specific binding member.
1-86. (canceled)
A method of detecting or diagnosing inflammatory bowel disease in a human or animal, wherein the method comprises the steps of
A method of treating inflammatory bowel disease in a patient, the method comprising administering to a patient a therapeutically effective amount of a medicament comprising a specific binding member which binds the ED-A isoform of fibronectin.
Dependencies are inferred from the claim text.